Meeting Abstract

Smoking Behaviour and the Severity and Progression of Organ Manifestations in Systemic Sclerosis: a Longitudinal European Scleroderma Trials and Research Group Study


AutorenlisteJaeger, V. K.; Valentini, G.; Hachulla, E.; Cozzi, F.; Distler, O.; Airo, P.; Czirjak, L.; Allanore, Y.; Siegert, E.; Rosato, E.; Matucci-Cerinic, M.; Caimmi, C.; Henes, J.; Carreira, P. E.; Smith, V; del Galdo, F.; Denton, C. P.; Ullman, S.; De Langhe, E.; Riccieri, V; Alegre-Sancho, J. J.; Rednic, S.; Mueller-Ladner, U.; Walker, U. A.

Jahr der Veröffentlichung2018

Seiten3S-3S

ZeitschriftSwiss Medical Weekly

Bandnummer148

ISSN1424-7860

eISSN1424-3997

VerlagSMW supporting association



Zitierstile

Harvard-ZitierstilJaeger, V., Valentini, G., Hachulla, E., Cozzi, F., Distler, O., Airo, P., et al. (2018) Smoking Behaviour and the Severity and Progression of Organ Manifestations in Systemic Sclerosis: a Longitudinal European Scleroderma Trials and Research Group Study, Swiss Medical Weekly, 148, p. 3S

APA-ZitierstilJaeger, V., Valentini, G., Hachulla, E., Cozzi, F., Distler, O., Airo, P., Czirjak, L., Allanore, Y., Siegert, E., Rosato, E., Matucci-Cerinic, M., Caimmi, C., Henes, J., Carreira, P., Smith, V., del Galdo, F., Denton, C., Ullman, S., De Langhe, E., ...Walker, U. (2018). Smoking Behaviour and the Severity and Progression of Organ Manifestations in Systemic Sclerosis: a Longitudinal European Scleroderma Trials and Research Group Study. Swiss Medical Weekly. 148, 3S.


Zuletzt aktualisiert 2025-02-04 um 01:17